CN220938291U - A kind of silk nonwoven medical dressing - Google Patents
A kind of silk nonwoven medical dressing Download PDFInfo
- Publication number
- CN220938291U CN220938291U CN202222368875.XU CN202222368875U CN220938291U CN 220938291 U CN220938291 U CN 220938291U CN 202222368875 U CN202222368875 U CN 202222368875U CN 220938291 U CN220938291 U CN 220938291U
- Authority
- CN
- China
- Prior art keywords
- layer
- silk
- adhesive
- adhesive tape
- medical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000010410 layer Substances 0.000 claims abstract description 89
- 239000004745 nonwoven fabric Substances 0.000 claims abstract description 62
- 239000012792 core layer Substances 0.000 claims abstract description 57
- 239000002390 adhesive tape Substances 0.000 claims abstract description 33
- 239000012790 adhesive layer Substances 0.000 claims abstract description 14
- 239000000835 fiber Substances 0.000 claims description 31
- 239000004744 fabric Substances 0.000 claims description 21
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 14
- 239000004820 Pressure-sensitive adhesive Substances 0.000 claims description 12
- 239000004831 Hot glue Substances 0.000 claims description 7
- 239000003522 acrylic cement Substances 0.000 claims description 7
- 239000011787 zinc oxide Substances 0.000 claims description 7
- 239000011247 coating layer Substances 0.000 claims description 6
- 230000002787 reinforcement Effects 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 27
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 13
- 230000008901 benefit Effects 0.000 abstract description 12
- 230000002439 hemostatic effect Effects 0.000 abstract description 12
- 230000029663 wound healing Effects 0.000 abstract description 10
- 230000003020 moisturizing effect Effects 0.000 abstract description 6
- 239000003963 antioxidant agent Substances 0.000 abstract description 3
- 230000003078 antioxidant effect Effects 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 238000012360 testing method Methods 0.000 description 26
- 208000032843 Hemorrhage Diseases 0.000 description 19
- 230000000740 bleeding effect Effects 0.000 description 19
- 238000000034 method Methods 0.000 description 19
- 230000006870 function Effects 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 12
- 230000006872 improvement Effects 0.000 description 12
- 241001465754 Metazoa Species 0.000 description 11
- 208000027418 Wounds and injury Diseases 0.000 description 11
- 230000023597 hemostasis Effects 0.000 description 11
- 206010015150 Erythema Diseases 0.000 description 10
- 206010070834 Sensitisation Diseases 0.000 description 10
- 108010013296 Sericins Proteins 0.000 description 10
- 206010052428 Wound Diseases 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- 230000008313 sensitization Effects 0.000 description 10
- 238000011282 treatment Methods 0.000 description 10
- 231100000321 erythema Toxicity 0.000 description 8
- 239000000284 extract Substances 0.000 description 8
- 238000004080 punching Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- 239000002131 composite material Substances 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 206010030113 Oedema Diseases 0.000 description 5
- 238000001467 acupuncture Methods 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 230000002209 hydrophobic effect Effects 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 239000013641 positive control Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000003075 superhydrophobic effect Effects 0.000 description 5
- 229920000742 Cotton Polymers 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 206010040914 Skin reaction Diseases 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 208000002847 Surgical Wound Diseases 0.000 description 4
- 238000009960 carding Methods 0.000 description 4
- 239000011651 chromium Substances 0.000 description 4
- 231100000135 cytotoxicity Toxicity 0.000 description 4
- 230000003013 cytotoxicity Effects 0.000 description 4
- 229910001385 heavy metal Inorganic materials 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000035483 skin reaction Effects 0.000 description 4
- 231100000430 skin reaction Toxicity 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 206010003226 Arteriovenous fistula Diseases 0.000 description 3
- 241000700199 Cavia porcellus Species 0.000 description 3
- VYZAHLCBVHPDDF-UHFFFAOYSA-N Dinitrochlorobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 VYZAHLCBVHPDDF-UHFFFAOYSA-N 0.000 description 3
- 108010022355 Fibroins Proteins 0.000 description 3
- 206010016717 Fistula Diseases 0.000 description 3
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 3
- 240000000249 Morus alba Species 0.000 description 3
- 235000008708 Morus alba Nutrition 0.000 description 3
- 239000002250 absorbent Substances 0.000 description 3
- 230000002745 absorbent Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 210000001105 femoral artery Anatomy 0.000 description 3
- 230000003890 fistula Effects 0.000 description 3
- 238000001631 haemodialysis Methods 0.000 description 3
- 230000000322 hemodialysis Effects 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 238000001095 inductively coupled plasma mass spectrometry Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 231100000344 non-irritating Toxicity 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000007670 refining Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 230000003068 static effect Effects 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 240000007472 Leucaena leucocephala Species 0.000 description 2
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 2
- 239000006142 Luria-Bertani Agar Substances 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 208000001647 Renal Insufficiency Diseases 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 206010058679 Skin oedema Diseases 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 206010042345 Subcutaneous haematoma Diseases 0.000 description 2
- 230000006750 UV protection Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006757 chemical reactions by type Methods 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 231100000263 cytotoxicity test Toxicity 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000013168 hemostasis test Methods 0.000 description 2
- 238000007731 hot pressing Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 201000006370 kidney failure Diseases 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000004224 protection Effects 0.000 description 2
- 239000011241 protective layer Substances 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000011343 solid material Substances 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010051814 Eschar Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010018999 Haemorrhage subcutaneous Diseases 0.000 description 1
- 101001121408 Homo sapiens L-amino-acid oxidase Proteins 0.000 description 1
- 101000827703 Homo sapiens Polyphosphoinositide phosphatase Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102100026388 L-amino-acid oxidase Human genes 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 102100023591 Polyphosphoinositide phosphatase Human genes 0.000 description 1
- 101100012902 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) FIG2 gene Proteins 0.000 description 1
- 101100233916 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) KAR5 gene Proteins 0.000 description 1
- 206010070835 Skin sensitisation Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000181 anti-adherent effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000012490 blank solution Substances 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 231100000333 eschar Toxicity 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- PLHJDBGFXBMTGZ-WEVVVXLNSA-N furazolidone Chemical compound O1C([N+](=O)[O-])=CC=C1\C=N\N1C(=O)OCC1 PLHJDBGFXBMTGZ-WEVVVXLNSA-N 0.000 description 1
- 229960001625 furazolidone Drugs 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 230000005661 hydrophobic surface Effects 0.000 description 1
- 238000010813 internal standard method Methods 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 238000000120 microwave digestion Methods 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 231100000370 skin sensitisation Toxicity 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229940060894 topex Drugs 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
- 239000009306 yunnan baiyao Substances 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Abstract
本实用新型公开了一种蚕丝无纺布医用敷贴,包括从上至下层叠复合的离型层、敷芯层和胶布层,所述敷芯层为蚕丝无纺布,所述离型层为胶布,用于覆盖保护敷芯层。本实用新型蚕丝无纺布医用敷贴的多功能是由蚕丝多种优点引起,实际上结构简单,由离型层、敷芯层、胶粘层和胶布层复合而成。敷芯层不需由止血材料、保湿材料、促伤口愈合材料、抗氧化成分和抗菌成分复合针刺而成,也不需要设计透气孔,制作工艺简单,价格低廉。
The utility model discloses a silk non-woven medical dressing, comprising a release layer, a core layer and an adhesive tape layer laminated from top to bottom, wherein the core layer is a silk non-woven fabric, and the release layer is an adhesive tape, which is used to cover and protect the core layer. The multifunctionality of the silk non-woven medical dressing of the utility model is caused by the multiple advantages of silk. In fact, the structure is simple, and the release layer, the core layer, the adhesive layer and the adhesive tape layer are composited. The core layer does not need to be compositely punctured with hemostatic materials, moisturizing materials, wound healing materials, antioxidant components and antibacterial components, and does not need to be designed with air holes. The manufacturing process is simple and the price is low.
Description
技术领域Technical Field
本实用新型涉及医用领域,涉及一种医用敷贴,具体涉及一种蚕丝无纺布医用敷贴。The utility model relates to the medical field, in particular to a medical dressing, and in particular to a silk non-woven fabric medical dressing.
背景技术Background technique
机体在相当多的情况下发生伴随出血的受伤。一般情况下,小伤口出血可由机体自身的凝血功能以及些简单护理措施即可解决。伤口和出血较轻微时,血液凝固功能正常,利用止血贴剂施以简单的急救即可解决。日常生活工作中,经常发生小创伤,需要止血包扎,以免失血过多、创口愈合受影响和发生感染。常见的邦迪苯扎氯铵贴,云南白药,呋喃西林创可贴基本作用相似,主要成分是消毒敷料和杀菌组分,敷料止血作用有限,透气性和促伤口愈合不良。Injuries accompanied by bleeding occur in quite a few cases. In general, bleeding from minor wounds can be solved by the body's own coagulation function and some simple care measures. When the wound and bleeding are minor, the blood coagulation function is normal, and simple first aid using a hemostatic patch can solve the problem. In daily life and work, minor trauma often occurs, which requires hemostatic bandages to avoid excessive blood loss, affected wound healing, and infection. Common Band-Aid benzalkonium chloride patches, Yunnan Baiyao, and furazolidone bandages have similar basic functions. The main ingredients are disinfectant dressings and bactericidal components. The dressings have limited hemostatic effects, and poor air permeability and wound healing.
临床的微创手术创口和静脉穿刺点也常需止血护理。微创手术的创口止血护理要求满足止血消炎、保持创口环境湿润和愈合等作用,常用含药液脱脂纱布敷贴或嵌入创口,不能很好地满足这些要求。临床上静脉穿刺后应立即对穿刺点止血,止血效果不好时,发生感染或者皮下出血/血肿。目前仍采用输液贴粘贴在静脉穿刺点上止血的传统方法,输液贴的构造只是单纯胶布中间有一薄棉片,止血时需按压,但是准确按压时间不易掌握,不能确保止血效果。特别地,动静脉内瘘是维持性血液透析患者常用的血管通路,内瘘的维护对患者频繁透析显得极为重要,正确压迫止血点是保护内瘘的重要环节,止血方法采用成团无菌纱布按压出血点,再用绷带或胶布固定包扎,按压不当会造成皮下血肿、外出血或损伤血管,甚至造成内瘘闭塞,适当的压力标准是既能止血又能感到血管震颤为好,中间还要松压,操作不便。Minimally invasive surgical wounds and venous puncture sites in clinical practice also often require hemostasis care. Minimally invasive surgical wound hemostasis care requires hemostasis and anti-inflammation, keeping the wound environment moist and healing, etc. The commonly used medicated degreased gauze is applied or embedded in the wound, which cannot meet these requirements well. In clinical practice, the puncture site should be hemostatic immediately after venous puncture. When the hemostasis effect is not good, infection or subcutaneous bleeding/hematoma will occur. At present, the traditional method of sticking an infusion patch on the venous puncture site to stop bleeding is still used. The structure of the infusion patch is simply a thin cotton piece in the middle of the tape, which needs to be pressed to stop bleeding, but the accurate pressing time is not easy to grasp, and the hemostasis effect cannot be guaranteed. In particular, arteriovenous fistula is a commonly used vascular access for patients undergoing maintenance hemodialysis. The maintenance of the fistula is extremely important for patients undergoing frequent dialysis. Correct compression of the hemostatic point is an important part of protecting the fistula. The hemostatic method uses a ball of sterile gauze to press the bleeding point, and then fix it with a bandage or adhesive tape. Improper pressure may cause subcutaneous hematoma, external bleeding or damage to blood vessels, and even cause fistula occlusion. The appropriate pressure standard is that it can both stop bleeding and feel blood vessel vibration. The pressure should be loosened in the middle, which is inconvenient to operate.
蚕丝是最细最轻柔的天然纤维,具有紧贴皮肤的舒适感,主要由丝胶蛋白和丝素蛋白组成,具有吸湿、透气、柔软、非常强的抗菌性能、耐燃、抗紫外线、抗氧化和较好延伸性等优点。桑蚕丝最特别的功能就是伤口和皮肤发炎都可以直接用桑蚕丝包扎,可加快伤口愈合。蚕丝纤维的吸湿性源于特定的组成与结构,许多亲水性极性基团的成分和空隙率高达30%左右的内部多孔性使得蚕丝纤维具有吸收空气中水分的能力,反之,潮湿的丝纤维在干燥的空气中放湿。由于丝胶的极性侧链的氨基酸占74.61%,其吸湿和放湿性能优于丝素。Silk is the thinnest and softest natural fiber, which is comfortable to the skin. It is mainly composed of sericin and fibroin, and has the advantages of moisture absorption, breathability, softness, very strong antibacterial properties, flame retardancy, UV resistance, oxidation resistance and good extensibility. The most special function of mulberry silk is that wounds and skin inflammations can be directly bandaged with mulberry silk, which can accelerate wound healing. The hygroscopicity of silk fiber comes from its specific composition and structure. The composition of many hydrophilic polar groups and the internal porosity of up to about 30% make silk fiber have the ability to absorb moisture in the air. On the contrary, wet silk fiber releases moisture in dry air. Since the amino acids in the polar side chains of sericin account for 74.61%, its moisture absorption and release properties are better than fibroin.
润湿性是指液体润湿固体表面的能力,用静态接触角θ来衡量,如果液滴在固体材料表面静态接触角为90°~180°时,我们称该材料表面为疏水表面;当液滴在固体材料表面静态接触角大于150°时,我们称该材料表面为超疏水表面。关于疏水方面有4种模型:Young’s方程适用于理想的光滑平整,组分均匀的表面。Wenzel模型考虑的仅仅是粗糙表面的凹槽处被液体填满的情况,这种情况下液体仅与一种介质相接触。而实际上,液体不仅仅是和一种介质接触。因此,Cassie和Baxter对Wenzel理论进行了相关的补充,提出了Cassie-Baxter模型,液体是与固体表面以及空气两种界面的复合接触;还有一种Wenzel和Cassie共存模型。研究人员发现了超疏水表面产生的原因:低表面能物质和粗糙结构同时存在于表面,比如“荷叶效应”是由表面能很低的蜡状物与微米和纳米结构相结合的复合结构。在材料上制备超疏水表面主要可以通过在材料表面形成粗糙结构,再用低表面能物质修饰或直接在表面能较低的材料表面构筑粗糙结构。人们对织物的功能要求兼具防水功能、抗菌功能、自清洁功能、抗紫外功能等等。超疏水织物凭借优异的防水、抗粘结和自清洁等性能可广泛应用在防水布和医用织物等领域。将织物经过200℃蒸汽熨烫后,由于高温作用,疏水的接枝链段从纤维内部迁移到纤维表面,使得棉织物的超疏水性得到增强。超疏水织物制备方法有的工艺复杂,工业条件也较为苛刻,制备成本也较高;有的对环境有一定危害,有的机械稳定性不够,易老化失效,实用性不强,无法大规模工业化生产。Wettability refers to the ability of a liquid to wet a solid surface, which is measured by the static contact angle θ. If the static contact angle of a droplet on the surface of a solid material is 90° to 180°, we call the surface of the material a hydrophobic surface; when the static contact angle of a droplet on the surface of a solid material is greater than 150°, we call the surface of the material a super-hydrophobic surface. There are four models for hydrophobicity: Young’s equation is applicable to ideal smooth and uniform surfaces. The Wenzel model only considers the situation where the grooves on the rough surface are filled with liquid, in which case the liquid is in contact with only one medium. In fact, the liquid is not only in contact with one medium. Therefore, Cassie and Baxter made relevant supplements to the Wenzel theory and proposed the Cassie-Baxter model, in which the liquid is in composite contact with two interfaces, the solid surface and the air; there is also a Wenzel and Cassie coexistence model. The researchers discovered the reason for the super-hydrophobic surface: low surface energy substances and rough structures exist on the surface at the same time, such as the "lotus effect" is a composite structure composed of waxy substances with very low surface energy and micro- and nano-structures. The preparation of super-hydrophobic surface on the material can be mainly done by forming a rough structure on the surface of the material, and then modifying it with low surface energy materials or directly constructing a rough structure on the surface of the material with low surface energy. People require the functional requirements of fabrics to have waterproof function, antibacterial function, self-cleaning function, anti-ultraviolet function, etc. Super-hydrophobic fabrics can be widely used in fields such as waterproof cloth and medical fabrics due to their excellent waterproof, anti-adhesive and self-cleaning properties. After the fabric is steam ironed at 200°C, due to the high temperature, the hydrophobic grafted chain segments migrate from the inside of the fiber to the surface of the fiber, so that the super-hydrophobicity of the cotton fabric is enhanced. Some methods for preparing super-hydrophobic fabrics have complex processes, harsh industrial conditions, and high preparation costs; some have certain hazards to the environment, some have insufficient mechanical stability, are prone to aging and failure, are not practical, and cannot be mass-produced industrially.
天然的耐燃性使得火焰不在面料上蔓延,桑蚕丝的防紫外线功能避免皮肤危害。无纺布医疗用品辅料吸水性强、不生菌、无刺激、不霉烂、不含荧光剂,是具有多种优点的先锋产品。人体接触安全可靠、无毒副作用、无刺激性、无致敏性、环保等优点。无纺布的制备方法包括针刺、水刺、熔喷和纺粘等方法。但是,市场上医用无纺布存在诸多缺点,包括功能单一、透气效果差,不能吸收渗液,均匀度不足、轻便性欠佳和促进伤口感染等。The natural flame resistance prevents the flame from spreading on the fabric, and the UV protection function of mulberry silk avoids skin damage. Non-woven medical accessories are highly absorbent, non-bacterial, non-irritating, non-mildew, and do not contain fluorescent agents. They are pioneer products with many advantages. They are safe and reliable for human contact, non-toxic and side effects, non-irritating, non-allergenic, and environmentally friendly. The preparation methods of non-woven fabrics include needle punching, spunlace, meltblowing, and spunbonding. However, there are many disadvantages of medical non-woven fabrics on the market, including single function, poor breathability, inability to absorb exudate, insufficient uniformity, poor portability, and promotion of wound infection.
综上,有必要研制这样的一种无纺布敷贴,它具有止血保湿、促进伤口愈合和抑菌等多种功能,还具有透气性能好和自行敷贴使用的优点。而蚕丝具有多种优点,有望制备出实现多种功能的医用无纺布敷贴。In summary, it is necessary to develop a non-woven dressing that has multiple functions such as hemostasis, moisturizing, promoting wound healing and antibacterial, and has the advantages of good breathability and self-applying. Silk has many advantages and is expected to be used to prepare a medical non-woven dressing that can achieve multiple functions.
发明内容Summary of the invention
针对现有技术中存在的技术问题,本申请提供了一种蚕丝无纺布医用敷贴。In view of the technical problems existing in the prior art, the present application provides a silk non-woven medical dressing.
一种蚕丝无纺布医用敷贴,包括从上至下层叠复合的离型层、敷芯层和胶布层,所述敷芯层为蚕丝无纺布,所述离型层为胶布,用于覆盖保护敷芯层。A silk nonwoven medical dressing comprises a release layer, a core layer and an adhesive tape layer which are laminated and composited from top to bottom. The core layer is a silk nonwoven fabric, and the release layer is an adhesive tape, which is used for covering and protecting the core layer.
优选的,所述敷芯层和胶布层之间还设有胶粘层。Preferably, an adhesive layer is provided between the core layer and the adhesive tape layer.
优选的,所述胶粘层为医用压敏胶、涂氧化锌热熔胶或丙烯酸胶。Preferably, the adhesive layer is medical pressure-sensitive adhesive, zinc oxide-coated hot melt adhesive or acrylic adhesive.
优选的,所述离型层通过压敏胶粘合在所述胶布层上,用于覆盖所述敷芯层。Preferably, the release layer is adhered to the adhesive tape layer by a pressure-sensitive adhesive to cover the core coating layer.
优选的,所述离型层的边缘或中间设有用于撕开的开口,以撕开露出敷芯层。Preferably, an opening for tearing is provided at the edge or the middle of the release layer, so as to tear open the release layer to expose the core coating layer.
优选的,所述胶布层为医用非织造布平布或医用非织造布弹力布。Preferably, the adhesive tape layer is a medical nonwoven plain cloth or a medical nonwoven elastic cloth.
优选的,所述离型层和胶布层为尺寸相同的长方形或正方形或圆形。Preferably, the release layer and the adhesive tape layer are rectangular, square or circular with the same size.
优选的,所述离型层和胶布层的长和宽尺寸或圆形直径均大于敷芯层的尺寸或直径。Preferably, the length and width or circular diameter of the release layer and the adhesive tape layer are greater than the size or diameter of the core coating layer.
下面对本申请做进一步详细说明:The following is a further detailed description of this application:
本申请的目的在于解决已有产品的不足,而提供一种功能多样、透气舒适、结构简单、使用方便和易储存的蚕丝无纺布医用敷贴。The purpose of the present application is to solve the deficiencies of existing products and to provide a silk non-woven medical dressing which has multiple functions, is breathable and comfortable, has a simple structure, is easy to use and easy to store.
本申请通过减少亲水的丝胶含量而增加疏水的丝素蛋白含量,也通过高温处理使得疏水组分迁移到纤维表面,无纺布表面粗糙多孔隙提高了疏水性结构程度。The present invention reduces the hydrophilic sericin content and increases the hydrophobic silk fibroin content, and also causes the hydrophobic component to migrate to the fiber surface through high temperature treatment. The rough and porous surface of the non-woven fabric improves the hydrophobic structure.
本申请所采用的技术方案是:一种多功能的蚕丝无纺布医用敷贴,从上到下包括层叠复合的离型层、敷芯层、胶粘层和胶布层,敷芯层是蚕丝无纺布纤网层,蚕丝经高温处理后,再由针刺或水刺制成。The technical solution adopted in this application is: a multifunctional silk non-woven medical dressing, which includes a laminated composite release layer, a core layer, an adhesive layer and a tape layer from top to bottom. The core layer is a silk non-woven fabric mesh layer. The silk is treated at high temperature and then made by needle punching or hydroentanglement.
本申请公开了一种多功能的蚕丝无纺布医用敷贴,从上到下包括层叠复合的离型层、敷芯层、胶粘层和胶布层,敷芯层是蚕丝无纺布纤网层,其中的蚕丝经高温物理处理后,再由针刺或水刺制成。因为蚕丝的吸湿性、促进伤口愈合、抗氧化性、抗菌性和透气性等优良特性,所以敷芯层不需由止血材料、保湿材料、促伤口愈合材料、抗氧化成分和抗菌成分复合针刺而成,也不需要设计透气孔,制作工艺简单,价格低廉。还因为蚕丝耐热耐燃性和抗紫外线,该医用敷贴具有稳定性高,储存易携带等优点。本医用敷料具有止血保湿、促进伤口愈合和抑菌等多种功能;还具有透气性能好和边缘不易发生卷边等优势,患者可自行对伤口进行换药处理,比较便利。The present application discloses a multifunctional silk non-woven medical dressing, which includes a laminated composite release layer, a core layer, an adhesive layer and a tape layer from top to bottom. The core layer is a silk non-woven fiber mesh layer, in which the silk is subjected to high-temperature physical treatment and then made by acupuncture or spunlace. Because of the excellent properties of silk such as hygroscopicity, promotion of wound healing, anti-oxidation, antibacterial and breathability, the core layer does not need to be formed by a composite acupuncture of hemostatic materials, moisturizing materials, wound healing materials, antioxidant components and antibacterial components, and does not need to be designed with air holes. The manufacturing process is simple and the price is low. Also, because silk is heat-resistant, flame-resistant and UV-resistant, the medical dressing has the advantages of high stability, easy storage and carrying. The medical dressing has multiple functions such as hemostasis, moisturizing, promotion of wound healing and antibacterial; it also has the advantages of good breathability and the edge is not easy to curl, so the patient can change the wound by himself, which is more convenient.
一种多功能的蚕丝无纺布医用敷贴,所述无纺布包括层叠复合的离型层、敷芯层、胶粘层和胶布层,敷芯层是蚕丝无纺布纤网层,蚕丝经高温处理后,得到蚕丝无纺布坯料,再由针刺或水刺制成。A multifunctional silk nonwoven medical dressing, the nonwoven fabric comprises a laminated composite release layer, a core layer, an adhesive layer and a tape layer, the core layer is a silk nonwoven web layer, the silk is treated at high temperature to obtain a silk nonwoven blank, which is then made by needle punching or hydroentanglement.
作为进一步改进方案,所述敷芯层为蚕丝无纺布纤网层,蚕丝经高温物理处理后,得到蚕丝无纺布坯料,再由针刺方法制成。As a further improvement scheme, the core layer is a silk non-woven fabric web layer. The silk is subjected to high-temperature physical treatment to obtain a silk non-woven fabric blank, which is then made by a needle punching method.
针刺制备方法包括如下步骤:The acupuncture preparation method comprises the following steps:
(1)坯料:将蚕茧经煮茧、缫丝、精炼和制丝工艺,其间可选用戊二醛交联固定丝胶蛋白来减少精炼过程的丝胶蛋白损耗,制成蚕丝棉被后,剪切成一定长宽的短布,提高疏水性的物理处理比如200℃到230℃高温烤制(0.5小时到2小时),即得蚕丝无纺布坯料;(1) Blank material: The silk cocoons are boiled, reeled, refined and processed, during which glutaraldehyde can be used to cross-link and fix sericin to reduce the loss of sericin in the refining process. After being made into a silk quilt, it is cut into short cloths of a certain length and width, and subjected to physical treatment to improve hydrophobicity, such as high-temperature baking at 200°C to 230°C (0.5 hour to 2 hours), to obtain a silk non-woven fabric blank;
(2)开松:将无纺布坯料先手动撕扯开松,再放入开松机进行开松预处理,在开松同时除去纤维杂质;(2) Opening: The nonwoven fabric blank is first manually torn and opened, and then placed in an opening machine for opening pretreatment, and fiber impurities are removed during opening;
(3)梳理:将开松后的纤维输送到单锡林双道夫梳理机中梳理成纤维网,为了减少纤网不匀率来提高质量,采用双道夫配置,可形成两层纤网,最后叠加在一起形成稍厚纤网;(3) Combing: The opened fibers are transported to a single-cylinder double-doffer carding machine to be combed into a fiber web. In order to reduce the unevenness of the fiber web and improve the quality, a double-doffer configuration is used to form two layers of fiber web, which are finally superimposed together to form a slightly thicker fiber web;
(4)铺网:采用交叉铺网,梳理机输出的薄纤网经斜帘到达顶端横帘,再进入夹持帘,来回摆动形成一定厚度的纤网,通过控制铺网层数可以精准调控布的厚度;(4) Laying the web: Cross-laying is adopted. The thin fiber web output by the carding machine passes through the oblique curtain to the top horizontal curtain, and then enters the clamping curtain, swinging back and forth to form a fiber web of a certain thickness. The thickness of the cloth can be accurately controlled by controlling the number of laying layers;
(5)针刺:用针刺机中的截面三角形(或其它形状)且棱边带钩刺的针,对蓬松的纤网反复针刺,加固成整体,形成针刺无纺布。(5) Acupuncture: Use a needle with a triangular cross-section (or other shape) and hooked edges in a needle punching machine to repeatedly needle the fluffy fiber web to strengthen it into a whole, forming a needle-punched nonwoven fabric.
作为进一步改进方案,所述敷芯层为蚕丝无纺布纤网层,蚕丝经提高疏水性的物理处理高温处理后,再由水刺方法制成。As a further improvement, the core layer is a silk non-woven fabric web layer, and the silk is physically treated at high temperature to improve its hydrophobicity and then made by a water-entanglement method.
水刺制备方法包括如下步骤:The spunlace preparation method comprises the following steps:
(1)坯料:将蚕茧经煮茧、缫丝、精炼和制丝工艺,其间可选用戊二醛交联固定丝胶蛋白来减少精炼过程的丝胶蛋白损耗,制成蚕丝棉被后,剪切成一定长宽的短布,经提高疏水性的物理处理200℃到230℃高温处理0.5小时到2小时,即得蚕丝无纺布坯料;(1) Blank material: The silk cocoons are boiled, reeled, refined and processed, during which glutaraldehyde can be used to cross-link and fix sericin to reduce the loss of sericin in the refining process. After being made into a silk quilt, it is cut into short cloths of a certain length and width, and subjected to a physical treatment to improve hydrophobicity at a high temperature of 200° C. to 230° C. for 0.5 hour to 2 hours to obtain a silk non-woven fabric blank;
(2)改性(选用):因为物理处理比如高温处理蚕丝中的丝胶蛋白热变性,亲水性减少,蚕丝无纺布坯料可选择亲水改性处理,部分地回复亲水性,达到更好的初始伤口粘附性,亲水处理方法包括等离子体、超声波、微波、月桂醇、双氧水、小苏打、食用碱和食用盐等;(2) Modification (optional): Because physical treatments such as high temperature treatment will cause the sericin in silk to denature and reduce its hydrophilicity, the silk non-woven fabric blank can be treated with hydrophilic modification to partially restore its hydrophilicity and achieve better initial wound adhesion. Hydrophilic treatment methods include plasma, ultrasound, microwave, lauryl alcohol, hydrogen peroxide, baking soda, edible alkali and edible salt;
(3)开松:将无纺布坯料先手动撕扯开松,再放入开松机进行开松预处理,在开松同时除去纤维杂质;(3) Opening: The nonwoven fabric blank is first manually torn and opened, and then placed in an opening machine for opening pretreatment, and fiber impurities are removed during opening;
(4)亲水改性或不改性处理的蚕丝无纺布坯料经过开松梳理、交叉铺网、水刺交缠、烘箱干燥和卷取存放,即得无纺布。(4) The hydrophilically modified or unmodified silk non-woven fabric blank is subjected to opening and combing, cross-laying, hydroentanglement, oven drying and winding and storage to obtain the non-woven fabric.
作为进一步改进方案,所述离型层是保护敷芯层的保护层。As a further improvement, the release layer is a protective layer for protecting the core coating layer.
作为进一步改进方案,所述离型层通过所述压敏胶粘合在胶布层上,并覆盖住所述敷芯层。As a further improvement, the release layer is bonded to the adhesive tape layer through the pressure-sensitive adhesive and covers the core coating layer.
作为进一步改进方案,所述离型层的边缘或中间设有用于撕开的开口,用于撕开露出贴覆伤口的敷芯层。As a further improvement, an opening for tearing is provided at the edge or in the middle of the release layer, so as to tear open the core layer for covering the wound.
作为进一步改进方案,靠近胶布那侧的敷芯层涂有医用压敏胶/涂氧化锌热熔胶/丙烯酸胶,用于粘合在胶布上。或者可采用热压辊将蚕丝无纺布与胶布热压粘合。As a further improvement, the core layer near the adhesive tape is coated with medical pressure-sensitive adhesive/zinc oxide hot melt adhesive/acrylic adhesive for bonding to the adhesive tape. Alternatively, a hot pressing roller can be used to heat-press the silk nonwoven fabric and the adhesive tape.
作为进一步改进方案,所述胶布上的胶粘层为医用压敏胶/涂氧化锌热熔胶/丙烯酸胶。As a further improvement scheme, the adhesive layer on the adhesive tape is medical pressure-sensitive adhesive/zinc oxide-coated hot melt adhesive/acrylic adhesive.
作为进一步改进方案,所述胶布层为医用非织造布平布或医用非织造布弹力布。As a further improvement, the adhesive tape layer is a medical nonwoven plain fabric or a medical nonwoven elastic fabric.
作为进一步改进方案,所述的离型层和胶布层为尺寸相同的长方形或正方形或圆形。As a further improvement, the release layer and the adhesive tape layer are rectangular, square or circular with the same size.
作为进一步改进方案,所述的离型层和胶布层的长和宽尺寸或圆形直径均大于敷料层的尺寸或直径。As a further improvement, the length and width or circular diameter of the release layer and adhesive tape layer are greater than the size or diameter of the dressing layer.
作为进一步改进方案,所述医用敷贴可用于日常生活工作的少量出血止血、微创手术创口止血、静脉穿刺后穿刺点的止血、肾功能衰竭患者血液透析的动静脉内瘘部位预防出血和保健护理贴垫等。As a further improvement, the medical dressing can be used for stopping bleeding in small amounts in daily life and work, stopping bleeding in minimally invasive surgical wounds, stopping bleeding at puncture points after venous puncture, preventing bleeding at arteriovenous fistula sites in hemodialysis patients with renal failure, and providing health care pads.
接下来进一步阐述具体方案。The specific plan is further elaborated next.
敷芯层为蚕丝无纺布纤网层,蚕丝经高温处理后,再由针刺、水刺或其他无纺布制备方法制成。针刺制备方法包括如下步骤:The core layer is a silk non-woven fabric web layer. The silk is treated at high temperature and then made by needle punching, spunlace or other non-woven fabric preparation methods. The needle punching preparation method includes the following steps:
(1)坯料:将蚕茧经煮茧、缫丝、精炼和制丝工艺,其间可选用戊二醛交联固定丝胶蛋白来减少精炼过程的丝胶蛋白损耗,制成蚕丝棉被后,剪切成一定长宽的短布,经过提高疏水性的物理处理比如高温200℃到230℃高温处理(0.5小时到2小时),即得蚕丝无纺布坯料;(1) Blank material: The silk cocoons are boiled, reeled, refined and processed, during which glutaraldehyde can be used to cross-link and fix sericin to reduce the loss of sericin in the refining process. After being made into a silk quilt, it is cut into short cloths of a certain length and width, and subjected to a physical treatment to improve the hydrophobicity, such as high temperature treatment at 200° C. to 230° C. (0.5 hour to 2 hours), to obtain a silk non-woven fabric blank;
(2)开松:将无纺布坯料先手动撕扯开松,再放入开松机进行开松预处理,在开松同时除去纤维杂质;(2) Opening: The nonwoven fabric blank is first manually torn and opened, and then placed in an opening machine for opening pretreatment, and fiber impurities are removed during opening;
(3)梳理:将开松后的纤维输送到单锡林双道夫梳理机中梳理成纤维网,为了减少纤网不匀率来提高质量,采用双道夫配置,可形成两层纤网,最后叠加在一起形成稍厚纤网;(3) Combing: The opened fibers are transported to a single-cylinder double-doffer carding machine to be combed into a fiber web. In order to reduce the unevenness of the fiber web and improve the quality, a double-doffer configuration is used to form two layers of fiber web, which are finally superimposed together to form a slightly thicker fiber web;
(4)铺网:采用交叉铺网,梳理机输出的薄纤网经斜帘到达顶端横帘,再进入夹持帘,来回摆动形成一定厚度的纤网,通过控制铺网层数可以精准调控布的厚度;(4) Laying the web: Cross-laying is adopted. The thin fiber web output by the carding machine passes through the oblique curtain to the top horizontal curtain, and then enters the clamping curtain, swinging back and forth to form a fiber web of a certain thickness. The thickness of the cloth can be accurately controlled by controlling the number of laying layers;
(5)针刺:用针刺机中的截面三角形(或其它形状)且棱边带钩刺的针,对蓬松的纤网反复针刺,加固成整体,形成针刺无纺布。(5) Acupuncture: Use a needle with a triangular cross-section (or other shape) and hooked edges in a needle punching machine to repeatedly needle the fluffy fiber web to strengthen it into a whole, forming a needle-punched nonwoven fabric.
离型层是保护敷芯层的保护层,通过所述压敏胶粘合在胶布上,并覆盖住所述敷芯层。离型层的边缘或中间设有用于撕开的开口,用于撕开露出贴覆伤口的敷芯层。离型层起到在产品使用前隔离胶布层的粘胶,保证胶布层的粘性。The release layer is a protective layer for protecting the core layer, which is bonded to the tape through the pressure-sensitive adhesive and covers the core layer. An opening for tearing is provided at the edge or in the middle of the release layer, which is used to tear open the core layer covering the wound. The release layer serves to isolate the adhesive of the tape layer before the product is used, thereby ensuring the stickiness of the tape layer.
靠近胶布那侧的敷芯层涂有医用压敏胶/涂氧化锌热熔胶/丙烯酸胶,用于粘合在胶布上。或者可采用热压辊将蚕丝无纺布布与胶布热压粘合,高效环保。The core layer near the tape is coated with medical pressure-sensitive adhesive/zinc oxide hot melt adhesive/acrylic adhesive for bonding to the tape. Alternatively, a hot pressing roller can be used to heat-press the silk non-woven fabric and the tape, which is efficient and environmentally friendly.
胶布层为医用非织造布平布或医用非织造布弹力布;胶布上的胶粘层为医用压敏胶/涂氧化锌热熔胶/丙烯酸胶。The adhesive tape layer is a medical nonwoven plain cloth or a medical nonwoven elastic cloth; the adhesive layer on the adhesive tape is a medical pressure-sensitive adhesive/zinc oxide-coated hot melt adhesive/acrylic adhesive.
离型层和胶布层为尺寸相同的长方形或正方形或圆形;离型层和胶布层的长和宽尺寸或圆形直径均大于敷料层的尺寸或直径。The release layer and the adhesive tape layer are rectangular, square or circular with the same size; the length and width or circular diameter of the release layer and the adhesive tape layer are larger than the size or diameter of the dressing layer.
本申请具有以下优点:This application has the following advantages:
(1)本申请蚕丝无纺布医用敷贴的多功能是由蚕丝多种优点引起,实际上结构简单,由离型层、敷芯层、胶粘层和胶布层复合而成。敷芯层不需由止血材料、保湿材料、促伤口愈合材料、抗氧化成分和抗菌成分复合针刺而成,也不需要设计透气孔,制作工艺简单,价格低廉。(1) The multifunctionality of the silk nonwoven medical dressing of the present application is caused by the multiple advantages of silk. In fact, the structure is simple, and it is composed of a release layer, a core layer, an adhesive layer and a tape layer. The core layer does not need to be formed by a compound needle puncture of hemostatic materials, moisturizing materials, wound healing materials, antioxidant components and antibacterial components, nor does it need to be designed with ventilation holes. The manufacturing process is simple and the price is low.
(2)还因为蚕丝耐热耐燃性和抗紫外线,该医用敷贴具有稳定性高,储存易携带等优点。(2) Because silk is heat-resistant, flame-resistant, and UV-resistant, the medical dressing has the advantages of high stability and easy storage and carrying.
(3)本医用敷料具有止血保湿、促进伤口愈合和抑菌等多种功能;还具有透气性能好和边缘不易发生卷边等优势,患者可自行对伤口进行换药处理,比较便利。(3) The medical dressing has multiple functions such as hemostasis, moisturizing, promoting wound healing and antibacterial. It also has the advantages of good air permeability and not prone to curling at the edges. Patients can change the dressing on the wound by themselves, which is relatively convenient.
(4)本申请医用敷贴用途较广,可用于日常生活工作的少量出血止血、微创手术创口止血、静脉穿刺后穿刺点的止血、肾功能衰竭患者血液透析的动静脉内瘘部位预防出血和保健护理贴垫等。(4) The medical dressing of the present application has a wide range of uses and can be used to stop bleeding in small amounts in daily life and work, stop bleeding in minimally invasive surgical wounds, stop bleeding at puncture points after venous puncture, prevent bleeding at the arteriovenous fistula site of hemodialysis patients with renal failure, and provide health care pads, etc.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
为了更清楚地描述本申请的技术方案,下面将结合附图作简要介绍。显而易见,这些附图仅是本申请记载的一些具体实施方式。本发明包括但不限于这些附图。In order to more clearly describe the technical solution of the present application, a brief introduction will be given below in conjunction with the accompanying drawings. Obviously, these drawings are only some specific implementation methods recorded in this application. The present invention includes but is not limited to these drawings.
图1为实施例1医用敷贴的结构示意图;FIG1 is a schematic structural diagram of a medical dressing according to Example 1;
图2为实施例2敷芯层蚕丝无纺布接触角;FIG2 is the contact angle of the core layer silk nonwoven fabric of Example 2;
图3为实施例3敷芯层蚕丝无纺布的扫描电镜图;FIG3 is a scanning electron microscope image of the core-layer silk nonwoven fabric of Example 3;
图4为实施例4敷芯层蚕丝无纺布的炽灼残渣;FIG4 is the ignition residue of the core-layer silk nonwoven fabric of Example 4;
图5为实施例8敷芯层蚕丝无纺布浸提液的体外细胞毒性;FIG5 is a graph showing the in vitro cytotoxicity of the extract of the core layer silk nonwoven fabric of Example 8;
图6为实施例11敷芯层蚕丝无纺布在小鼠股动脉出血模型的止血效果。FIG6 shows the hemostatic effect of the core layer silk nonwoven fabric of Example 11 in a mouse femoral artery bleeding model.
具体实施方式Detailed ways
为了进一步理解本发明,下面将结合实施例对本发明的示范方案进行描述。这些描述只是举例说明本发明蚕丝无纺布医用敷贴的部分特征和优点,而非限制本发明的保护范围。In order to further understand the present invention, the exemplary scheme of the present invention will be described below in conjunction with the embodiments. These descriptions are only examples of some features and advantages of the silk nonwoven medical dressing of the present invention, and do not limit the protection scope of the present invention.
下述实施例中所使用的实验方法如无特殊说明,均为常规方法;所用的材料、试剂等,如无特殊说明,均可从商业途径得到。Unless otherwise specified, the experimental methods used in the following examples are all conventional methods; the materials, reagents, etc. used, unless otherwise specified, can be obtained from commercial channels.
下面结合附图对本申请蚕丝无纺布医用敷贴做详细说明:The following is a detailed description of the silk nonwoven medical dressing of the present application in conjunction with the accompanying drawings:
一种蚕丝无纺布医用敷贴,包括从上至下层叠复合的离型层1、敷芯层2和胶布层3,所述敷芯层2为蚕丝无纺布(即蚕丝无纺布纤网层),所述离型层1为胶布,用于覆盖保护敷芯层2,该胶布采用医用非织造布平布(或也可以采用医用非织造布弹力布)。所述敷芯层2和胶布层3之间还设有胶粘层,所述胶粘层为医用压敏胶(或者也可以采用涂氧化锌热熔胶或丙烯酸胶),敷芯层2通过胶粘层固定在胶布层3上,所述胶布层3采用医用非织造布平布(或也可以采用医用非织造布弹力布)。所述离型层1和胶布层3的尺寸大小相同并且大于敷芯层2的大小尺寸。所述离型层1通过压敏胶粘合在所述胶布层3上,用于覆盖所述敷芯层2。所述离型层1的边缘(或也可以在中间设置)设有用于撕开的开口11,以撕开露出敷芯层2。A silk nonwoven medical dressing comprises a release layer 1, a core layer 2 and a tape layer 3 which are laminated from top to bottom. The core layer 2 is a silk nonwoven fabric (i.e., a silk nonwoven fabric web layer), and the release layer 1 is a tape used to cover and protect the core layer 2. The tape is made of a medical nonwoven fabric (or a medical nonwoven elastic fabric). An adhesive layer is also provided between the core layer 2 and the tape layer 3. The adhesive layer is a medical pressure-sensitive adhesive (or a zinc oxide-coated hot melt adhesive or an acrylic adhesive). The core layer 2 is fixed to the tape layer 3 through the adhesive layer. The tape layer 3 is made of a medical nonwoven fabric (or a medical nonwoven elastic fabric). The release layer 1 and the tape layer 3 are of the same size and are larger than the size of the core layer 2. The release layer 1 is bonded to the tape layer 3 by a pressure-sensitive adhesive to cover the core layer 2. The edge of the release layer 1 (or it can also be arranged in the middle) is provided with an opening 11 for tearing, so as to tear it open to expose the core layer 2.
优选的,所述离型层1和胶布层3为尺寸相同的长方形或正方形或圆形。Preferably, the release layer 1 and the adhesive tape layer 3 are rectangular, square or circular with the same size.
实施例1Example 1
制备医用敷贴的蚕丝无纺布敷芯层Preparation of silk nonwoven core layer for medical dressing
蚕丝无纺布利用针刺机的刺针穿刺作用,使蚕丝纤网中纤维互相缠结,从而形成蚕丝无纺布敷芯层。制备过程是将短纤维,依次经过开松、梳理和针刺加固。在针刺加工中,针刺次数、针刺深度、针刺密度、刺针型号及刺针排列方式是影响成品蓬松及厚度的主要因素。针刺机参数举例:针刺频率800刺/每分钟,植针密度2200根/每米,针刺深度5mm。本发明不限于该参数。Silk non-woven fabrics use the puncture action of the needles of the needle loom to entangle the fibers in the silk web, thus forming a core layer of silk non-woven fabrics. The preparation process is to open, comb and reinforce the short fibers with needles in sequence. In the needling process, the number of needling times, needling depth, needling density, needle model and needle arrangement are the main factors affecting the fluffiness and thickness of the finished product. Examples of needling machine parameters: needling frequency 800 punctures/minute, needle density 2200 needles/meter, needling depth 5mm. The present invention is not limited to this parameter.
结果成功制备出蓬松较薄的蚕丝无纺布敷芯层,适合制备医用敷贴。Results A fluffy and thin silk nonwoven core layer was successfully prepared, which is suitable for preparing medical dressings.
实施例2敷芯层蚕丝无纺布疏水值测定Example 2 Determination of hydrophobicity of core layer silk nonwoven fabric
接触角测定用光学接触角测量仪(OCA 50AF,DataPhysics Instruments GmbH,Germany)测定,图2(左图)测得的接触角近150°,已知接触角大于90°表示疏水,说明敷芯层蚕丝无纺布为疏水性质;图2(右图)的棉花接触角为0°,表明棉花超级亲水。The contact angle was measured using an optical contact angle meter (OCA 50AF, DataPhysics Instruments GmbH, Germany). The contact angle measured in Figure 2 (left) is nearly 150°. It is known that a contact angle greater than 90° indicates hydrophobicity, indicating that the core layer silk non-woven fabric is hydrophobic; the contact angle of cotton in Figure 2 (right) is 0°, indicating that cotton is super hydrophilic.
实施例3敷芯层蚕丝无纺布的扫描电镜观察Example 3 Scanning electron microscopy observation of core layer silk nonwoven fabric
扫描电镜拍摄无纺布微观情况(结果见图3),用Image J测量扫描电镜照片的纤维直径,约10μm。The nonwoven fabric was photographed under a scanning electron microscope (see Figure 3 for the results), and the fiber diameter of the scanning electron microscope photograph was measured using Image J, which was about 10 μm.
实施例4敷芯层蚕丝无纺布的炽灼残渣Example 4 Ignition residue of core layer silk nonwoven fabric
敷芯层蚕丝无纺布的炽灼残渣测定按照药典第四部通则0800“限量检查法”—0841炽灼残渣检查法测定。取供试品1.0-2.0g或各品种项下规定的重量,置已炽灼至恒重的坩埚中,精密称定,缓缓炽灼至完全炭化,放冷;在700-800℃炽灼至恒重,即得。结果见图4,蚕丝无纺布的炽灼残渣大于蚕丝原料,两者都小于1%。The ignition residue of the core layer silk non-woven fabric is determined according to the ignition residue test method of 0800 "Limited Inspection Method" - 0841 in the fourth part of the Pharmacopoeia. Take 1.0-2.0g of the test sample or the weight specified under each variety, put it in a crucible that has been ignited to constant weight, accurately weigh it, slowly ignite it until it is completely carbonized, and cool it; ignite it at 700-800℃ to constant weight. The results are shown in Figure 4. The ignition residue of the silk non-woven fabric is greater than that of the silk raw material, and both are less than 1%.
实施例5敷芯层蚕丝无纺布的干燥失重Example 5 Drying weight loss of core layer silk nonwoven fabric
敷芯层蚕丝无纺布的干燥失重测定按照药典第四部通则0800“限量检查法”—0831干燥失重测定法。取供试品,混合均匀,取约1g或各品种项下规定的重量,置与供试品相同条件下干燥至恒重的扁形称量瓶中,精密称定,除另有规定外,在105℃干燥至恒重,由减失的重量和取样量计算供试品的干燥失重。结果:无纺布干燥失重0.25%。The drying loss of the core layer silk non-woven fabric is determined according to the Pharmacopoeia Part IV General Chapter 0800 "Limited Inspection Method" - 0831 Drying loss determination method. Take the test sample, mix it evenly, take about 1g or the weight specified under each variety, put it in a flat weighing bottle dried to constant weight under the same conditions as the test sample, accurately weigh it, and dry it at 105℃ to constant weight unless otherwise specified. Calculate the drying loss of the test sample from the lost weight and the sample amount. Result: The drying loss of the non-woven fabric is 0.25%.
实施例6敷芯层蚕丝无纺布的重金属含量Example 6 Heavy Metal Content of Core Layer Silk Nonwoven Fabric
按照GB/T 37837-2019四极杆电感耦合等离子体质谱方法通则测定重金属元素铬(Cr)、砷(As)、镉(Cd)、铅(Pb)和汞(Hg)的含量。所用的主要设备有Perkin Elmer Nex ION300X型ICP-MS和上海屹尧TOPEX微波消解仪。测定方法:采用在线内标法,将供试品溶液与混合内标溶液混合后进入ICP-MS仪。测定时选取同位素为52Cr、63Cu、75As以74Ge作为内标;111Cd以115In作为内标;202Hg、208Pb以209Bi作为内标。分别对系列混合标准溶液、空白溶液及供试品溶液进行分析,采用标准曲线法定量。The contents of heavy metal elements chromium (Cr), arsenic (As), cadmium (Cd), lead (Pb) and mercury (Hg) were determined according to the general rules of quadrupole inductively coupled plasma mass spectrometry method GB/T 37837-2019. The main equipment used were Perkin Elmer Nex ION300X ICP-MS and Shanghai Yiyao TOPEX microwave digestion instrument. Determination method: The online internal standard method was adopted, and the test solution was mixed with the mixed internal standard solution and then entered into the ICP-MS instrument. During the determination, the isotopes of 52 Cr, 63 Cu, and 75 As were selected with 74 Ge as the internal standard; 111 Cd was selected with 115 In as the internal standard; 202 Hg and 208 Pb were selected with 209 Bi as the internal standard. The series of mixed standard solutions, blank solutions and test solutions were analyzed respectively, and the standard curve method was used for quantification.
结果5种重金属含量都小于1mg/kg。以国际元素IHE标准“ICH HarmonisedGuideline,16December 2014”的Cr为例,肠胃外暴露1.07mg/day,按照每次使用不超过10g止血材料来计算,5种重金属未超过标准。Results showed that the contents of the five heavy metals were all less than 1 mg/kg. Taking Cr in the international element IHE standard "ICH Harmonised Guideline, 16 December 2014" as an example, parenteral exposure was 1.07 mg/day, and calculated based on the use of no more than 10g of hemostatic material each time, the five heavy metals did not exceed the standard.
实施例7敷芯层蚕丝无纺布的抑菌试验Example 7 Antibacterial test of core layer silk nonwoven fabric
试验前,取1×1cm 1mm厚的蚕丝无纺布样本,放入24孔板的每个孔中。UV照射1h后,细菌悬液(10μL,108CFUs/mL菌)滴到材料表面。37℃培养2h后,每个孔加入1000μL无菌PBS重悬存活细菌。取出20μL重悬菌液,100倍稀释获得最终稀释菌液。20μL稀释菌液涂布到LB琼脂板表面,37℃培养。过夜培养后,对每个LB琼脂板上形成的CFUs进行计数。结果表明,蚕丝无纺布对大肠杆菌(ATCC25922)有明显杀菌作用,但对金黄色葡萄球菌(ATCC29213)无杀菌作用。Before the test, a 1×1cm 1mm thick silk nonwoven fabric sample was taken and placed in each well of a 24-well plate. After UV irradiation for 1h, a bacterial suspension (10μL, 10 8 CFUs/mL bacteria) was dripped onto the surface of the material. After culturing at 37℃ for 2h, 1000μL of sterile PBS was added to each well to resuspend the surviving bacteria. 20μL of the resuspended bacterial solution was taken out and diluted 100 times to obtain the final diluted bacterial solution. 20μL of the diluted bacterial solution was spread on the surface of the LB agar plate and cultured at 37℃. After overnight culture, the CFUs formed on each LB agar plate were counted. The results showed that the silk nonwoven fabric had a significant bactericidal effect on Escherichia coli (ATCC25922), but had no bactericidal effect on Staphylococcus aureus (ATCC29213).
实施例8蚕丝无纺布的体外细胞毒性试验Example 8 In vitro cytotoxicity test of silk nonwoven fabric
体外细胞毒性按照GBT16886.5用L929细胞测试。图6结果表明,1mm厚度的2号针刺无纺布(X2)24h 100%浸提液对L929细胞干预24h的体外毒性为Ⅰ级反应,其无纺布原材料为1级反应,均为合格;阳性对照(0.3%苯酚)的细胞相对增殖率(relative growt h rate,RGR)为Ⅱ级反应,为中重度细胞毒性;强生速即纱阳性止血材料的24h 100%浸提液加到培养基,立即呈现黄色浑浊,显微镜下看不到贴壁细胞,干预L929 24h的RGR为Ⅲ级反应,为中重度细胞毒性。综合比较,粉状和针刺无纺布JCJ的体外细胞毒性试验评价结果表明,其安全性比市售强生速即纱更安全。In vitro cytotoxicity was tested with L929 cells according to GBT16886.5. The results in Figure 6 show that the in vitro toxicity of the 100% extract of the 1mm thick No. 2 needle-punched non-woven fabric (X2) for 24 hours to L929 cells for 24 hours was a grade I reaction, and the non-woven raw material was a grade 1 reaction, both of which were qualified; the relative growth rate (RGR) of the positive control (0.3% phenol) was a grade II reaction, which was moderate to severe cytotoxicity; the 24h 100% extract of the positive hemostatic material of the Johnson Speed Yarn was added to the culture medium, and it immediately became yellow and turbid, and no adherent cells were seen under the microscope. The RGR of the intervention of L929 for 24 hours was a grade III reaction, which was moderate to severe cytotoxicity. Comprehensive comparison, the in vitro cytotoxicity test evaluation results of the powdered and needle-punched non-woven fabric JCJ showed that its safety was safer than the commercially available Johnson Speed Yarn.
实施例9Example 9
蚕丝无纺布的皮肤刺激试验Skin irritation test of silk nonwoven fabrics
按照GB/T 16886.10开展皮肤刺激试验。Carry out skin irritation test in accordance with GB/T 16886.10.
选择体重为200-250g的皮肤健康无损伤的SD大鼠作为受试动物对象(雌),自由饮水进食,在SPF环境下饲养一周后开始试验。SD rats weighing 200-250 g with healthy skin and no damage were selected as test animals (female), and were allowed to drink water and eat freely. The experiment began after being raised in an SPF environment for one week.
实验部位为大鼠的背部,分为实验组和对照组,每组5只动物,实验组使用制备的浸提液上清液,对照组为生理盐水。在每只受试动物同时进行两组实验,即实验组和对照组,分别有两个试验材料区域和两个空白对照材料区域。The experimental site was the back of the rats, which were divided into an experimental group and a control group, with 5 animals in each group. The experimental group used the prepared extract supernatant, and the control group used normal saline. Two groups of experiments were conducted simultaneously on each test animal, namely the experimental group and the control group, with two test material areas and two blank control material areas respectively.
在试验前24h将动物背部脊柱两侧约8cm×8cm区域被毛除去,作为试验和观察部位。为了便于观察,可能需反复除毛。24 hours before the test, remove the hair of the animal's back spine in an area of about 8cm×8cm on both sides as the test and observation area. In order to facilitate observation, it may be necessary to remove the hair repeatedly.
将制备的浸提液滴到大小为2.5cm×2.5cm的4层医用纱布块上,浸提液的用量以能浸透纱布块为宜,一般每块纱布滴0.5mL,敷贴于受试动物背部两侧。将无菌生理盐水滴在同样大小的纱布块上并敷贴在对照接触部位。The prepared extract was dripped onto a 4-layer medical gauze piece of 2.5 cm × 2.5 cm in size. The amount of extract used should be sufficient to soak the gauze piece. Generally, 0.5 mL was dripped onto each gauze piece and applied to both sides of the back of the test animal. Sterile saline was dripped onto a gauze piece of the same size and applied to the control contact area.
用1层称量纸覆盖后,用胶布固定,后用绷带(半封闭性或封闭性)固定敷贴4h,取下敷贴片,使用持久性墨水对接触部位标记,并用除去残留试验材料(如用温水或其他适宜的无刺激性溶剂清洗并小心拭干)。Cover with a layer of weighing paper, fix with adhesive tape, and then fix with a bandage (semi-occlusive or occlusive) for 4 hours. Remove the patch, mark the contact area with permanent ink, and remove the residual test material (such as washing with warm water or other suitable non-irritating solvents and carefully drying).
观察24h动物受试区域皮肤红斑和水肿情况,并记录各接触部位情况,同时根据表(皮肤反应分类评分标准)对皮肤出现红斑水肿的情况记分。Observe the skin erythema and edema of the animal test area for 24 hours, record the conditions of each contact site, and score the skin erythema and edema according to Table (Skin Reaction Classification Scoring Standard).
表1皮肤反应记分表Table 1 Skin reaction scoring table
结果表明,除了10% SDS阳性对照部位,按照表1计分为1-4分,其他部位经布状和生理盐水处理,皮肤反应计分都为0分,说明焦蚕茧材料浸提液生物安全性较高。The results showed that except for the 10% SDS positive control site, which was scored 1-4 points according to Table 1, the skin reaction scores of other sites treated with cloth and saline were all 0 points, indicating that the biosafety of the charred cocoon material extract was relatively high.
实施例10Example 10
蚕丝无纺布的豚鼠致敏试验Guinea pig sensitization test of silk nonwoven fabrics
按照GB/T 16886.10开展皮肤致敏试验。采用GBT 16886.10-2017的封闭贴敷试验(Buehler)。实验组为蚕丝无纺布浸提液,阴性对照组为生理盐水,阳性对照组是浓度为乙醇配制的0.5%的2,4-二硝基氯苯溶液。该实验分为二个阶段:诱导阶段(7天+14天),激发阶段(6小时)。准备阶段:a)在试验开始之前彻底剪除或剔除动物全部试验部位被毛;b)对于局部应用,将三层吸水性纱布块(2.5cm×2.5cm)浸透试验样品,贴敷于动物的除毛部位,再用封闭性包扎带固定(6土0.5)h;c)对于局部应用,将适宜的滤纸或纱布,贴敷于除毛皮肤上,再用封闭式包扎带缠绕动物躯干固定。主试验:(1)三周诱导阶段。在实验前24h,在豚鼠左上背3×3cm区域备毛作为试验部位;在实验开始前先使用70%乙醇清洁受试区域,放置三层吸水性纱布块(2.5cm×2.5cm)浸透试验样品;1周中连续3d重复该步骤,同法操作3周。(2)激发阶段。最后一次诱导贴敷后(14±1)d,在每只动物的去毛未试部位涂抹相应溶液,并贴上敷贴片,用1层称量纸覆盖后,用胶布固定;(6士0.5)小时后除去包扎带和敷贴片,使用持久性墨水对接触部位标记,并用除去残留试验材料;除去激发敷贴片24h和48h按表1给出的分级标准进行评分(皮肤反应分类评分标准),观察实验动物受试激发部位的红斑和水肿情况。The skin sensitization test was carried out in accordance with GB/T 16886.10. The closed patch test (Buehler) of GBT 16886.10-2017 was used. The experimental group was the silk non-woven fabric extract, the negative control group was saline, and the positive control group was 0.5% 2,4-dinitrochlorobenzene solution prepared with ethanol. The experiment was divided into two stages: induction stage (7 days + 14 days) and stimulation stage (6 hours). Preparation stage: a) Before the start of the experiment, completely cut or remove the hair of all test parts of the animal; b) For local application, soak a three-layer absorbent gauze block (2.5cm×2.5cm) with the test sample, apply it to the hair removal part of the animal, and then fix it with a closed bandage for (6±0.5)h; c) For local application, apply appropriate filter paper or gauze to the hair removal skin, and then wrap the animal trunk with a closed bandage to fix it. Main test: (1) Three-week induction stage. 24 hours before the experiment, prepare the hair of the 3×3cm area on the upper left back of the guinea pig as the test site; before the experiment, use 70% ethanol to clean the test area, and place three layers of absorbent gauze (2.5cm×2.5cm) soaked with the test sample; repeat this step for 3 consecutive days in 1 week, and operate in the same way for 3 weeks. (2) Provocation phase. (14±1) days after the last induction patch, apply the corresponding solution to the untested area of each animal, and apply the patch, cover it with a layer of weighing paper, and fix it with adhesive tape; remove the bandage and patch after (6±0.5) hours, mark the contact area with permanent ink, and remove the residual test material; remove the provocation patch 24h and 48h, and score according to the grading standard given in Table 1 (skin reaction classification scoring standard), and observe the erythema and edema of the provocation site of the experimental animals.
根据表1和表2标准进行记分和分级,豚鼠致敏性评价结果见表3。激发24h后,阳性对照组受试动物的受试部位均出现不同程度的红斑和水肿现象,致敏程度达100%,根据Mafhusson致敏反应分级标准,阳性对照组致敏反应为Ⅴ级,表明0.5%2,4-二硝基氯苯溶液(DNCB)在该实验条件下对豚鼠有极强的致敏作用。阴性对照和浸提液组均未发现皮肤有显著红斑或水肿现象,实验组与阴性对照组无明显差别,计分为0,无致敏作用。According to the standards in Table 1 and Table 2, the scoring and grading were performed, and the results of the sensitization evaluation of guinea pigs are shown in Table 3. 24 hours after the stimulation, the tested parts of the animals in the positive control group showed different degrees of erythema and edema, and the sensitization degree reached 100%. According to the Mafhusson sensitization reaction grading standard, the sensitization reaction of the positive control group was grade V, indicating that 0.5% 2,4-dinitrochlorobenzene solution (DNCB) had a strong sensitization effect on guinea pigs under this experimental condition. No significant erythema or edema was found in the skin of the negative control group and the leaching liquid group. There was no significant difference between the experimental group and the negative control group, and the score was 0, indicating no sensitization effect.
表2 Mafhusson致敏反应分级标准Table 2 Mafhusson sensitization grading standard
表3豚鼠致敏性评价结果Table 3 Guinea pig sensitization evaluation results
实施例11Embodiment 11
蚕丝无纺布在小鼠股动脉出血模型的止血试验Hemostasis test of silk nonwoven fabric in mouse femoral artery bleeding model
小鼠股动脉出血模型的止血试验结果表明(图6),蚕丝无纺布(X3)的止血耗时与强生速(Q)即纱相当,约40s,烧灰蚕茧(H)止血耗时略高于强生速即纱,但也无显著差异,无纺布的止血耗时显著短于原材料(X0,约60s)。The results of the hemostasis test in the mouse femoral artery bleeding model showed (Figure 6) that the hemostasis time of the silk non-woven fabric (X3) was equivalent to that of the strong speed yarn (Q), about 40s, and the hemostasis time of the burnt ash cocoon (H) was slightly higher than that of the strong speed yarn, but there was no significant difference. The hemostasis time of the non-woven fabric was significantly shorter than that of the raw material (X0, about 60s).
上述说明书中描述的实施例只是本发明的部分实施例,在不脱离本发明保护构思和范围的前提下,在本发明基础上的各种变化和改进,都落入要求保护的本发明范围内。The embodiments described in the above specification are only some embodiments of the present invention. Without departing from the protection concept and scope of the present invention, various changes and improvements based on the present invention fall within the scope of the present invention to be protected.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202222368875.XU CN220938291U (en) | 2022-09-07 | 2022-09-07 | A kind of silk nonwoven medical dressing |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202222368875.XU CN220938291U (en) | 2022-09-07 | 2022-09-07 | A kind of silk nonwoven medical dressing |
Publications (1)
Publication Number | Publication Date |
---|---|
CN220938291U true CN220938291U (en) | 2024-05-14 |
Family
ID=91015991
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202222368875.XU Active CN220938291U (en) | 2022-09-07 | 2022-09-07 | A kind of silk nonwoven medical dressing |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN220938291U (en) |
-
2022
- 2022-09-07 CN CN202222368875.XU patent/CN220938291U/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2974694T3 (en) | New type of wound dressing for hemostasis | |
CN103948960B (en) | A kind of porous silicone rubber/polyurethane double-layer artificial skin containing nano-silver and its preparation method | |
CN100400019C (en) | Emergency wound dressing and its preparation method | |
WO2015081769A1 (en) | Wound dressing with three-layer structure and preparation method thereof | |
CN104869954B (en) | Adhesive article | |
CN109248333A (en) | A kind of medical dressing and its preparation method and application of antibacterial wound healing | |
WO2012094264A2 (en) | Adhesively attachable material and method for fabrication thereof | |
US8679525B2 (en) | Wound care dressing and method using same | |
CN102198159A (en) | Medicament for the treatment of burns and sore and ulcer diseases, and wound plaster made of the same | |
US8529942B2 (en) | Wound care dressing | |
Zhang et al. | Water-retaining and separable adhesive hydrogel dressing for wound healing without secondary damage | |
CN109289079B (en) | Medical dressing for inhibiting scars and preparation method and application thereof | |
CN114748670B (en) | Nonwoven hemostatic gauze and preparation method and application thereof | |
CN220938291U (en) | A kind of silk nonwoven medical dressing | |
CN1298972A (en) | Hydro-entangled non-woven chitin fibre cloth and its production method | |
CN111282015A (en) | Artificial skin scar removing plaster | |
CN107412842B (en) | Preparation method of alginate wound dressing with thrombin | |
GB2464970A (en) | Wound dressing comprising fibrous plugs | |
CN106075552B (en) | Medical hemostatic sponge and preparation method thereof | |
TWI334878B (en) | Degradable dressing for wound healing appilcation | |
CN109432479B (en) | Antibacterial hemostatic hydrocolloid oily yarn and preparation method thereof | |
CN111557790A (en) | Antibacterial and disinfectant nanofiber medical dressing | |
CN100479867C (en) | Preparation method of glue adhesion amnion | |
CN109276748A (en) | One kind prevents adhesion promoting healing antibacterial bearing hydrocolloid dressing and preparation method thereof | |
JP4263871B2 (en) | Wound dressing and method for producing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GR01 | Patent grant | ||
GR01 | Patent grant |